Status:
TERMINATED
Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19.
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Coronavirus
Eligibility:
All Genders
Brief Summary
In December 2019, a pneumonia due to a novel coronavirus (SARS-CoV-2) emerged in the city of Wuhan, in China. In a few weeks, the number of confirmed cases of SARS-CoV-2 infection has dramatically inc...
Detailed Description
Procedures added by the research: Blood sampling for determination of the presence of SARS-CoV-2 type M immunoglobulins or type G immunoglobulins. Blood sampling for whole exome sequencing
Eligibility Criteria
Inclusion
- High/moderate risk contact with a laboratory-confirmed SARS-CoV-2 case;
- Within the 14 days following the last contact with a laboratory-confirmed SARS-CoV-2 case;
- Obtaining informed consent.
Exclusion
- Subject included in the CoV-CONTACT study
- Subject deprived of freedom
- Subject under a legal protective measure
Key Trial Info
Start Date :
March 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT04322279
Start Date
March 9 2020
End Date
December 31 2022
Last Update
January 22 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon
Besançon, France, 25030
2
Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin
Bordeaux, France, 33076
3
Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand
Clermont-Ferrand, France, 63000
4
Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne
Dijon, France, 21 079